4th Quarter - Report

PHARMAVITE LLC for PHARMAVITE LLC

A later version of this report replaces this one, so LegiList's totals use the current version instead. This page shows this version exactly as filed.

Firm
Client
Income
—
Expenses
$70,000
Expense method
A: Lobbying Disclosure Act definitions

Versions of this report

Every filing the register holds for this firm, client and period, oldest first. The most recent one is the version LegiList counts.

Filing Filed Amount Counted
4th Quarter - Report (this page) Jan 21, 2020 $70,000 Replaced
4th Quarter - Amendment Jan 29, 2020 $70,000 Yes

What was lobbied

One issue area, each in the filer's own words, with who lobbied on it and where.

Food Industry (safety, labeling, etc.) FOO

Funding for Office of Dietary Supplement Programs at FDA Support for a legal pathway for CBD Support for the inclusion of a multivitamin in SNAP benefits Support for the allowance of dietary supplements in HSA/FSA benefits

LobbyistCovered position, as disclosed
INGRID LEBERT New —

Contacted: HOUSE OF REPRESENTATIVES; Food & Drug Administration (FDA); SENATE

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.